Crossref
Real-world Use of the Aripiprazole Two-injection Start Regimen in Schizophrenia and Bipolar Disorder: A Cluster Analysis
Clinical Psychopharmacology and Neuroscience · 08.07.2026
DOI: 10.9758/cpn.26.1435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 08.07.2026. Verfasst von Mustafa Kurt und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kurt, M., & Taşdemir, A. (2026). Real-world Use of the Aripiprazole Two-injection Start Regimen in Schizophrenia and Bipolar Disorder: A Cluster Analysis. Clinical Psychopharmacology and Neuroscience. https://doi.org/10.9758/cpn.26.1435
Vancouver
Kurt M, Taşdemir A. Real-world Use of the Aripiprazole Two-injection Start Regimen in Schizophrenia and Bipolar Disorder: A Cluster Analysis. Clinical Psychopharmacology and Neuroscience. 2026. doi:10.9758/cpn.26.1435
BibTeX
@article{Kurt2026,
author = {Kurt, Mustafa and Taşdemir, Ali},
title = {Real-world Use of the Aripiprazole Two-injection Start Regimen in Schizophrenia and Bipolar Disorder: A Cluster Analysis},
journal = {Clinical Psychopharmacology and Neuroscience},
year = {2026},
doi = {10.9758/cpn.26.1435}
}
EUVIMED